Magdalena Plebanski, PhD

Royal Melbourne Institute of Technology University (RMIT), Australia

Disclosure(s): AstraZeneca: Grant/Research Support

Poster(s):

• (P-98) The Platform Trial In COVID-19 priming and BOOsting (PICOBOO): the immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second booster (fourth dose) in BNT162b2 primed individuals aged 18-< 50 and 50-< 70 years old.
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT